BEAM Alliance and global partners call for urgent action on new reimbursement models for life-saving antibiotics
The BEAM Alliance and the co-signatories of this paper urge the EU and its Member States to urgently act and fix the broken economics around investment into the development and commercialization of antimicrobials.
Registration now open:
International Masterclass AMR 29 SEP delivered digitally: 2 = 1!
- Science, Health-Economic & Societal impact
- Global causes and global solutions
- Bottom-up, interactive approach
- International Experts involved